Accelerate Diagnostics (NASDAQ:AXDX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Accelerate Diagnostics (AXDX) operate in?

Accelerate Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

Accelerate Diagnostics Stock (NASDAQ: AXDX) stock price, news, charts, stock research, profile.

Open	$1.63
Close	$1.67
Volume / Avg.	28.75K / 62.00K
Day Range	$1.63 - $1.70
52 Wk Range	0.73 - 5.41
Market Cap	$43.83M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	3.03%
Days to Cover	7.68

Recent News

Accelerate Diagnostics Reports Q1 Loss, Misses Revenue Estimates

Accelerate Diagnostics (NASDAQ: AXDX) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $1.70 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Avi Kapoor

Why Accelerate Diagnostics (AXDX) Stock Is Down 38%

Accelerate Diagnostics shares are trading lower by 38% during Friday's session. The company priced an underwritten public offering of 6,860,659 units at $1.50 each.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.63
Close	$1.67
Volume / Avg.	28.75K / 62.00K
Day Range	$1.63 - $1.70
52 Wk Range	0.73 - 5.41
Market Cap	$43.83M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	3.03%
Days to Cover	7.68

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Accelerate Diagnostics (AXDX) stock?

You can purchase shares of Accelerate Diagnostics (NASDAQ:AXDX) through any online brokerage.

View our list of the best stock brokerages

Who are Accelerate Diagnostics (AXDX) competitors?

Other companies in Accelerate Diagnostics’s space includes: Precision Optics Corp (NASDAQ:POCI), Nexalin Technology (NASDAQ:NXL), Lucid Diagnostics (NASDAQ:LUCD), NeuroOne Medical Tech (NASDAQ:NMTC) and Femasys (NASDAQ:FEMY).

What is the forecast, or price target, for Accelerate Diagnostics (AXDX) stock?

Accelerate Diagnostics has a consensus price target of $1.00.

What is the current price for Accelerate Diagnostics (AXDX)?

The stock price for Accelerate Diagnostics (NASDAQ: AXDX) is $1.67 last updated November 21, 2024 at 4:00 PM EST.

Does Accelerate Diagnostics (AXDX) pay a dividend?

There are no upcoming dividends for Accelerate Diagnostics.

When is Accelerate Diagnostics (NASDAQ:AXDX) reporting earnings?

Accelerate Diagnostics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Accelerate Diagnostics (AXDX) going to split?

There is no upcoming split for Accelerate Diagnostics.

What sector and industry does Accelerate Diagnostics (AXDX) operate in?

Accelerate Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

Comments

Accelerate Diagnostics

Accelerate Diagnostics (AXDX) Forecast